Palo Alto Investors LP - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$3,820,000
+1.4%
6,974,8540.0%0.29%
-1.0%
Q1 2016$3,766,000
-39.8%
6,974,8540.0%0.29%
-16.1%
Q4 2015$6,260,000
+10.8%
6,974,8540.0%0.35%
+27.9%
Q3 2015$5,650,000
+107.1%
6,974,854
+669.6%
0.27%
+124.8%
Q2 2015$2,728,000
+84.6%
906,263
+50.2%
0.12%
+65.8%
Q1 2015$1,478,000603,4000.07%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 1,320,000$9,425,00010.46%
RA Capital Management 4,869,261$34,767,0004.11%
GREAT POINT PARTNERS LLC 400,000$2,856,0001.23%
Healthcare Value Capital, LLC 100,000$714,0000.69%
DSC Advisors, L.P. 175,000$1,250,0000.63%
Quantitative Systematic Strategies LLC 107,416$803,0000.47%
Visium Asset Management, LP 4,093,890$29,230,0000.43%
Rhenman & Partners Asset Management AB 201,171$1,436,0000.42%
EAM Investors, LLC 277,807$1,984,0000.40%
ESSEX INVESTMENT MANAGEMENT CO LLC 354,861$2,534,0000.39%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders